| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 18.41B | 18.81B | 18.84B | 16.66B | 19.59B | 19.74B |
| Gross Profit | 18.18B | 18.30B | 18.80B | 16.62B | 19.55B | 18.20B |
| EBITDA | 2.24B | 2.76B | 3.32B | 1.65B | 3.87B | 1.79B |
| Net Income | 1.20B | 1.56B | 1.93B | 758.00M | 2.53B | 1.00B |
Balance Sheet | ||||||
| Total Assets | 45.62B | 41.90B | 46.65B | 42.67B | 47.94B | 49.21B |
| Cash, Cash Equivalents and Short-Term Investments | 22.21B | 17.99B | 21.87B | 16.19B | 17.74B | 17.31B |
| Total Debt | 3.64B | 2.28B | 361.00M | 628.00M | 592.00M | 491.00M |
| Total Liabilities | 18.45B | 14.44B | 17.64B | 14.85B | 17.87B | 20.10B |
| Stockholders Equity | 27.17B | 27.46B | 29.01B | 27.82B | 30.06B | 29.11B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -573.00M | 3.40B | 1.32B | 1.65B | 4.42B |
| Operating Cash Flow | 0.00 | -524.00M | 3.79B | 1.61B | 2.09B | 4.86B |
| Investing Cash Flow | 0.00 | -296.00M | -524.00M | -320.00M | -169.00M | -44.00M |
| Financing Cash Flow | 0.00 | -3.04B | -1.14B | -2.82B | -1.38B | -1.12B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥61.12B | 10.05 | 17.21% | 4.27% | 7.60% | 7.20% | |
76 Outperform | ¥46.71B | 7.03 | 6.18% | 4.42% | 1.56% | -9.90% | |
72 Outperform | ¥1.98T | 3.01 | 20.02% | 2.63% | 23.96% | 179.16% | |
72 Outperform | ¥189.50B | 7.61 | 7.40% | 5.60% | 3.10% | 17.73% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
63 Neutral | ¥16.74B | 9.36 | ― | 2.86% | 36.31% | 52.62% | |
50 Neutral | ¥30.01B | -8.03 | ― | ― | -33.10% | -49.56% |